Effects of Subcutaneous and Intravenous Recombinant Human Erythropoietin Treatments on Body Iron in Rats
Recombinant human erythropoietin (rHuEPO) is used widely in clinical practice for correcting anemia related to renal failure, cancer chemotherapy, HIV infection, premature infants, and chronic diseases. Recombinant human erythropoietin is known to affect body iron status that may result in functiona...
| Hoofdauteur: | |
|---|---|
| Formaat: | Thesis |
| Taal: | English English |
| Gepubliceerd in: |
2009
|
| Online toegang: | http://psasir.upm.edu.my/id/eprint/11540/1/FPV_2009_15.pdf |